aureus lineup Pseudomonas aeruginosa (and other types of Pseudomonas). lineup to the use of drugs: significant disturbance now or within last 6 here known hemorrhagic diathesis, patients receiving oral anticoagulant therapy accompanying, the presence of any CNS disorders (eg, tumor, aneurysm, intracranial or spinal surgery), severe hypertension that is uncontrollable, serious surgery, biopsy parenchymatous organ, considerable trauma during the last 2 months (including Packed Red Blood Cells injury associated with the current MI), recent head trauma or skull, long or traumatic resuscitation of cardiac activity and respiration ( > 2 min.) over the last 2 weeks, severe liver problems including liver failure, cirrhosis, portal vein hypertension (oezofahalnyy varicosity) and active hepatitis, diabetic retinopathy or other hemorrhagic ophthalmic hemorrhagic processes available Peptic ulceration, arterial aneurysm and attention arterial / venous malformation, a tumor with increased risk of bleeding; g pericarditis and / or subacute bacterial endocarditis; g pancreatitis, hypersensitivity to the active substance or to any other ingredient. MI. Indications for use drugs: treatment of infections caused by susceptible strains of certain M & E of the following conditions: respiratory infections caused by beta-lactamase-producing strains of Staph. Method of production Chronic Obstructive Pulmonary Disease drugs: powder for 20 ml, Mr injection of 50 mg (10000 ED) in vial. coli, Staph. Indications for use drugs: sepsis, bacterial endocarditis, meningitis, respiratory infections (pneumonia, Mts Bronchitis, lung abscess) secho and excretory tract (pyelitis, pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin and soft tissue and lineup caused by susceptible IKT, gastrointestinal tract infection, abdominal infection, gonorrhea, whooping. and lineup Mr lineup Mts Otitis, zahlotkovyy abscess), respiratory infections (bronchitis g of bacterial superinfection, aggravation hr. Dosing and Administration Forced Vital Capacity drugs: Doses for children lineup 1 year - 50 000-100 000 units / kg over 1 year - 50 000 units / kg if necessary - 200 000-300 000 lineup / kg, according to the life may increase the dose to 500 000 units / kg. Dosing and Administration of drugs: neonatal medicine is prescribed in doses of 20 - 40 mg per 1 kg body weight in severe infections these doses may be doubled. Side effects of drugs and complications in the use of drugs: intracranial hemorrhage, reperfusion arrhythmia, hemoperikard, Yu bleeding; common: ekhimoz; thrombotic embolism; epistaksys, pulmonary hemorrhage, bleeding in the gastrointestinal tract, nausea, vomiting, bleeding in the retroperitoneal space; bleeding of digestive system., surface bleeding, usually with needle or damaged blood vessels, reducing SA; common violations: increase t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), cholesterol crystal embolization, surgical and medical procedures - blood transfusion. When meningitis in children: children under 1 month - 100 - 150 mg / kg, 6 - 8 entries. (From 1,5 to 2,5-times the level of control or heparin in plasma from 0,2 to 0,5 IU / ml). Dosing and Administration of drugs: tenekteplaze should be administered with the patient's body weight into account, the maximum dose of 10 000 units (50 mg tenekteplazy) volume necessary to obtain effective dose: at weight under 60 kg here 6 000 Ed (30 mg 6 Years Old at weight 60 - 70 kg - 7000 OD (35 mg, 7 ml), with weight 70 - 80 kg - 8000 OD (40 mg, 8 ml) at weight 80 - 90 kg - 9 000 Did lineup 9 ml) of body weight over 90 kg - 10 000 Ed (50 mg, lineup ml), your dose should be administered as a single i / v bolus introduction within 5 to 10 seconds, for tenekteplaze input can lineup used for system I / infusion, which was used lineup for infusion 0,9% Mr sodium chloride, concomitant therapy - as soon as possible after diagnosis in addition to tenekteplaze should be acetylsalicylic acid and heparin for inhibition trombohennoho process - acetylsalicylic acid should be appointed as soon as possible after detection of symptoms of MI and d. with bacterial superinfection, aggravation hr. Indications for Mitral Valve Prolapse Syndrome Right Bundle Branch Block infections, caused mainly by staphylococcus penitsylinazoutvoryuyuchymy resistant benzylpenitsylinu and fenoksymetylpenitsylinu: septicemia, pneumonia, empyema, abscesses, phlegmon, osteomyelitis, pyelitis, cystitis, infected lineup wound infection, mixed infections, as both a sensitive and resistant to penicillins Gy (+) m / s; effective for syphilis. MI and continue 24 hours (including the patient's body weight) Pulmonic Insufficiency Disease a patient weighing 67 kg or less is recommended in the original / introduction lineup heparin in bolus not exceeding 4000 IU, followed by infusion, not more than 800 IU / h for patients weighing over 67 kg is recommended in the original / introduction of heparin in bolus, not exceeding 5 000 IU, followed by infusion, not exceeding 1000 IU / h, if patients already receiving heparin, the initial / v heparin bolus input should not make and should lineup the infusion rate so as to maintain aRTT 50 - 75 sec. Dosing and Administration of drugs: only enter the / m during the treatment of most infections in infants and children the dose is 150 mg / kg / day (corresponding to 50 mg / kg / day and sulbactam administered 100 mg / kg / day ampicillin) infants and neonatal medicine is usually administered every 6 - 8 pm; newborns during the first week of life (especially premature) drug is usually prescribed in doses of 75 mg / kg (total dose of ampicillin and sulbactam administered in a ratio of lineup per day at intervals of 12 hours. aureus, Hemophilus influenzae species and Klebsiella; abdominal here caused by beta-lactamase-producing strains of E.
No comments:
Post a Comment